Evaluation of Beauty Care Before Chemotherapy in Women With Breast Cancer (BEAUTY)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Gustave Roussy, Cancer Campus, Grand Paris
ClinicalTrials.gov Identifier:
NCT01459003
First received: October 24, 2011
Last updated: May 5, 2014
Last verified: May 2014
  Purpose

Evaluation of beauty care in women receiving adjuvant chemotherapy for breast cancer


Condition Intervention Phase
Breast Cancer
Other: beauty care
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Official Title: Evaluation of Beauty Care Before Chemotherapy in Women With Breast Cancer

Resource links provided by NLM:


Further study details as provided by Gustave Roussy, Cancer Campus, Grand Paris:

Primary Outcome Measures:
  • quality of life questionnaire [ Time Frame: up to 12 months ] [ Designated as safety issue: No ]
    body image


Enrollment: 400
Study Start Date: October 2011
Study Completion Date: April 2014
Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: experimental Other: beauty care
beauty care performed before each chemo cycle
No Intervention: control

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • breast cancer with no metastasis receiving adjuvant chemotherapy

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01459003

Locations
France
Gustave Roussy
Villejuif, Val de Marne, France, 94805
Sponsors and Collaborators
Gustave Roussy, Cancer Campus, Grand Paris
Investigators
Study Chair: Mahasti Saghatchian, MD Gustave Roussy, Cancer Campus, Grand Paris
  More Information

No publications provided

Responsible Party: Gustave Roussy, Cancer Campus, Grand Paris
ClinicalTrials.gov Identifier: NCT01459003     History of Changes
Other Study ID Numbers: 2011-A00811-40, 2010/1632
Study First Received: October 24, 2011
Last Updated: May 5, 2014
Health Authority: France: Committee for the Protection of Personnes

Additional relevant MeSH terms:
Breast Neoplasms
Neoplasms by Site
Neoplasms
Breast Diseases
Skin Diseases

ClinicalTrials.gov processed this record on August 28, 2014